Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by Saxmanon Jul 23, 2024 9:39pm
111 Views
Post# 36145471

Green Wave Advises…

Green Wave Advises…
With the comment period now closed, the best case scenario for a final ruling could come in 30 days, which falls EOB Aug 21st; The final day of the DNC is Aug 22nd. 
 
I do not think this is a coincidence. Nonetheless, the discussion around policy change has gone on way too long (10+ years), and we all know, as do our politicians (on both sides of the aisle), reform is inevitable. As a reminder, nobody took the stage at the RNC against rescheduling  (the only Biden policy/action that was not called out).
 
There have undoubtedly been countless head-fakes in the past, but the difference here, IMHO, is the weight of the HHS findings and recommendations.  
 
Continuing to delay action on this issue serves no purpose. It's time to take the next step towards de-scheduling and the establishment of a national protocol on standards and product safety. In other words, it's time to finally act (S*hit or get off the "Pot" - no pun intended).  
 
Bring on the Garland Memo, Updated FinCen guidance etc and lets look forward to a great end of summer (and beyond). 
<< Previous
Bullboard Posts
Next >>